AGEROS Trademark

Trademark Overview

On Thursday, October 15, 2020, a trademark application was filed for AGEROS with the United States Patent and Trademark Office. The USPTO has given the AGEROS trademark a serial number of 90257531. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, March 16, 2021. This trademark is owned by Amazentis SA. The AGEROS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

House mark for pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging

Research and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging
ageros

General Information

Serial Number90257531
Word MarkAGEROS
Filing DateThursday, October 15, 2020
Status601 - ABANDONED - EXPRESS
Status DateTuesday, March 16, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesHouse mark for pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging
Goods and ServicesResearch and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 3, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmazentis SA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEcublens 1024
CH

Trademark Events

Event DateEvent Description
Tuesday, March 16, 2021ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Tuesday, March 16, 2021ABANDONMENT - EXPRESS MAILED
Monday, March 15, 2021TEAS EXPRESS ABANDONMENT RECEIVED
Monday, March 15, 2021ASSIGNED TO EXAMINER
Monday, March 15, 2021ASSIGNED TO EXAMINER
Thursday, December 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 19, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

ageros diseases conditions disorders metabolic renal aging related ophthalmological neurodegenerative musculoskeletal